About
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Sector Focus
Healthcare
Immunology
Data
Analytics
Personalized Treatment
Drug Development
Computational Biology
Life Sciences
Therapeutics
Ultrasound
Series Focus
Series A
Series E
Series F
Strategic
Cheque Size
$38.0M - $239.0M
Score Breakdown
40Deal Activity
27Track Record
20Visibility
30Profile
100Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Catalio Capital Management?
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
What kind of firm is Catalio Capital Management?
Catalio Capital Management is a Venture Capital.
Where is Catalio Capital Management based?
Catalio Capital Management is based in United States.
What sectors does Catalio Capital Management focus on?
Catalio Capital Management focuses on Healthcare, Immunology, Data, Analytics.
Similar Investors